VSL#3 and conjugated linoleic acid ameliorate colitis and inflammation-driven colorectal cancer
Viladomiu, M., M. Pedragosa, C. De Simone, R. Hontecillas and J. Bassaganya-Riera (2011) VSL#3 and conjugated linoleic acid ameliorate colitis and inflammation-driven colorectal cancer, American Society for Clinical Ontology Annual Meeting, Chicago, IL.
Inflammatory bowel disease (IBD) increases the risk of colorectal cancer. Manipulating the gut microbiota has been proposed to decrease inflammation and colorectal cancer. Bacterial species in the VSL#3 mixture are capable of producing conjugated linoleic acid (CLA), a polyunsaturated fatty acid with demon strated anti-inflammatory and anti-carcinogenic effects. This study aimed to compare the anti-carcinogenic anti-inflammatory efficacies of dietary CLA versus VSL#3 treatment in mouse models of IBD and colon cancer.